Absent Semen with Ejaculation: Evaluation and Management
When a patient presents with no semen during ejaculation (aspermia), you must first distinguish between retrograde ejaculation and true ejaculatory duct obstruction by examining post-ejaculatory urine for sperm—this single test determines your entire management pathway. 1
Diagnostic Algorithm
Step 1: Confirm Aspermia and Check Post-Ejaculatory Urine
- Obtain post-ejaculatory urine immediately after orgasm and centrifuge it to look for sperm 2, 3
- If sperm are present in urine → Retrograde ejaculation confirmed
- If no sperm in urine → Proceed to Step 2
Step 2: Evaluate for Obstruction vs. Production Failure
Perform physical examination focusing on:
- Testicular size and consistency: Normal-sized, descended testes with dilated/indurated epididymides or absent vas deferens suggest obstructive azoospermia 1
- Atrophic testes suggest spermatogenic failure (non-obstructive azoospermia) 1
Obtain hormonal evaluation:
- FSH <7.6 IU/L with normal testicular size → Obstructive azoospermia likely
- FSH >7.6 IU/L with testicular atrophy → Non-obstructive azoospermia (production failure) 1
Step 3: Further Characterization if Obstruction Suspected
If you suspect distal obstruction (CBAVD or ejaculatory duct obstruction):
- Low volume (<1.4 mL) + acidic pH (<7.0) = distal genital tract obstruction blocking seminal vesicle contribution 1
- Normal pH essentially rules out complete distal obstruction 1
Management Based on Etiology
Retrograde Ejaculation (Sperm in Post-Ejaculatory Urine)
Primary approach: Sperm retrieval from urine for assisted reproduction 2, 3
Management options:
- Alkalinize urine with oral medications or add sperm wash media into bladder before ejaculation to preserve sperm viability 3, 4
- Pharmacotherapy (sympathomimetics) to convert retrograde to antegrade ejaculation 4, 5
- Harvest sperm from post-orgasm urine for use in assisted reproductive techniques 2, 3, 4
- Surgical bladder neck reconstruction (rarely needed) 4
Critical caveat: Drug treatment is ineffective when postmasturbation urine contains no spermatozoa—this indicates a different problem entirely 5
Obstructive Azoospermia (No Sperm in Urine, Normal FSH, Normal Testes)
For congenital obstruction (CBAVD):
- Mandatory: Test female partner for cystic fibrosis gene mutations due to high CF carrier risk in males with CBAVD 6
- Treatment: Sperm retrieval with assisted reproduction (success rates 25-65%) 6
For acquired obstruction (post-vasectomy, infection, iatrogenic):
- Microsurgical reconstruction or transurethral resection of ejaculatory ducts depending on obstruction level 6
- Alternative: Sperm retrieval with assisted reproduction 6
Non-Obstructive Azoospermia (No Sperm in Urine, Elevated FSH, Atrophic Testes)
Genetic testing is mandatory before proceeding:
- Karyotype testing for azoospermia with elevated FSH or testicular atrophy 1
- Y-chromosome microdeletion analysis for azoospermic males with suspected impaired sperm production 1
Management:
- Identify and treat reversible causes of low sperm production 6
- Testicular sperm extraction (TESE) effective in 30-70% of cases 6
- Once sperm found: IVF with ICSI achieves pregnancy rates 20-50% 6
Common Pitfalls to Avoid
Failing to check post-ejaculatory urine: This is the single most important diagnostic step—without it, you may subject patients to unnecessary invasive procedures like testicular biopsy 2
Assuming all aspermia is retrograde ejaculation: True ejaculatory duct obstruction presents similarly but requires completely different management 1
Not testing the female partner for CF mutations when CBAVD is diagnosed—this is a critical genetic counseling issue 6
Attempting drug therapy for retrograde ejaculation when post-ejaculatory urine shows no sperm—this indicates the problem is not retrograde flow 5
Using home/mail-in semen tests for definitive diagnosis—these lack the accuracy of specialized andrology laboratory testing and cannot substitute for proper evaluation 1